Bret Stephens’ Pharmapologetics
Now, when the demand for both innovation and access is high, it’s time to think outside the box and reevaluate the relationship between pharmaceutical drugs and the patent system. Perhaps a prize system is in order, or maybe a formal guarantee from firms receiving BARDA grants that the drugs will not be patented.Featured Publications
Low-Energy Fridays: The Truth About Jewish Space Lasers
A Tale of Two Electricity Forecasts
The State of Telehealth Policy: January 2026
Trump’s Plan to Cap Credit Card Interest Rates Won’t Fix Affordability Issues
R Street’s 2026 Insurance Agenda: Look Back, Look Ahead







